GlobeNewswire

Radixx International Appoints John Elieson as President and CEO

Dela

 

ORLANDO, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- Radixx International, an industry-leading provider of tailored airline reservation, distribution and merchandising systems, today announced that it has appointed John Elieson as President & CEO. Ron Peri, Radixx's Founder and former CEO, will continue to serve as Chairman of Radixx's Board of Directors.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1e4e5090-f5a9-457c-8e2d-b61664ed2a78

Mr. Elieson will be responsible for implementing the overall strategic direction of Radixx and will oversee the company's daily operations. Prior to joining Radixx, Mr. Elieson spent 29 years at Sabre where he most recently served as Senior Vice President of Global Accounts and Traveler Experience in their Travel Network division. During his career at Sabre, Mr. Elieson has had a variety of responsibilities including leading global sales for Sabre's Airline Solutions division and leading Global Marketing and Corporate Strategy for Travelocity.  The majority of Mr. Elieson's distinguished career has been spent in direct and indirect airline distribution, both offline and online.

"John is the ideal fit for Radixx as the company continues to make significant strides and grow its customer base," said Ron Peri, Founder and Chairman of Radixx International. "We are confident that John's background and relevant experience within the global travel industry, particularly as they pertain to airline solutions, will prove to be of tremendous value. We are very pleased to welcome John to Radixx and look forward to his future contributions to the company."

"John is a talented leader with a proven track record for driving growth and building highly effective teams," said Kurt R. Jaggers, a member of Radixx's Board of Directors and a Managing Director at TA Associates, which completed a significant investment in Radixx in September 2016. "We believe that John's management skills and travel sector knowledge will prove beneficial for Radixx. On behalf of the Board of Directors, I would like to sincerely thank Ron Peri for his service, passion and dedication to Radixx and its customers, partners and employees, and we look forward to his continued contributions as Chairman."

Commenting on his appointment, Mr. Elieson said, "I am thrilled and grateful to have the opportunity to join Radixx, a company that I have followed and respected for many years. As a result of the hard work of both leadership and staff, Radixx is well positioned to take advantage of its leading technology and unique value proposition to significantly grow its customer base. I am impressed with the Radixx team and am eager to work closely with them to build upon the company's strong reputation and momentum."

John Elieson Biography
John Elieson is President & CEO of Radixx International. Prior to joining Radixx, Mr. Elieson served as Senior Vice President of Global Accounts and Traveler Experience for Sabre Travel Network, a technology provider to the global travel industry. He spent nearly three decades with Sabre and its former parent company, American Airlines, in a variety of functional areas including operations, training, software development, consulting, business development, sales & account management, marketing, product development, portfolio management, pricing & revenue management, business intelligence and strategy. During his tenure, Mr. Elieson successfully led several multi-billion dollar negotiations creating significant value for all parties. He earned an MBA from Vanderbilt University and has conducted business and managed staff all over the world. Mr. Elieson serves on several boards for businesses, universities, municipalities and non-profit organizations.

About Radixx International
Radixx International, Inc., headquartered in Orlando, Florida, is now delivering its sixth-generation passenger service system, Galaxy PSS. Galaxy is the first fully web-native PSS system and can be deployed in any public or private data center. It has been certified to operate from the smallest cloud network to the largest most demanding environments. Galaxy provides a customizable, complete enterprise system that caters to the needs of hybrid, low-cost and traditional airlines, including support for interlining, code sharing and distribution through GDS. Founded in 1993 and now hosting 50 airlines on six continents, Radixx' fully integrated, cloud-based solutions support all airline business models. Radixx recently partnered with TA Associates, a leading global growth private equity firm. For more information, visit www.radixx.com.

Media Contact:
John Beisner
Bond Moroch
jbeisner@bondmoroch.com
+1.504.323.8337

 
 



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Radixx Solutions International, Inc. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum